Results for tag: "Cyclobutyrol"

Cyclobutyrol is a type of gastrointestinal drug used to treat a variety of gastrointestinal disorders, including irritable bowel syndrome, ulcerative colitis, and Crohn's disease. It is a prodrug, meaning it is converted into an active form in the body, and is believed to work by blocking the release of certain chemicals in the gut that can cause inflammation. Cyclobutyrol is available in both oral and topical forms, and is generally well-tolerated with few side effects. The cyclobutyrol market is a growing one, with increasing demand for treatments for gastrointestinal disorders. The market is expected to benefit from the increasing prevalence of gastrointestinal disorders, as well as the development of new formulations and delivery systems. Some companies in the cyclobutyrol market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, and Pfizer. Show Less Read more